Category: Life Sciences
Global Life Sciences
-
Veterinary Rapid Testing
... at a CAGR of 8.3% over the analysis period 2024-2030. Rapid Testing Kits, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end ... Read More
-
Veterinary X-ray
... CAGR of 6.6% over the analysis period 2024-2030. Computed Radiography, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$360.6 Million by the end of the analysis ... Read More
-
Glaucoma Surgery Devices
... at a CAGR of 21.0% over the analysis period 2024-2030. Traditional Surgery, one of the segments analyzed in the report, is expected to record a 20.8% CAGR and reach US$3.1 Billion by the end of ... Read More
-
Healthcare Personal Protective Equipment
... 2030, growing at a CAGR of 9.3% over the analysis period 2024-2030. Respiratory Protection, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$29.3 Billion by the ... Read More
-
Laboratory Gas Generators
... at a CAGR of 12.9% over the analysis period 2024-2030. Nitrogen Gas Generators, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$435.7 Million by the end ... Read More
-
Medical Carts
... CAGR of 14.7% over the analysis period 2024-2030. Mobile Computing, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$4.5 Billion by the end of the analysis ... Read More
-
Medical Device Contract Manufacturing
... 2030, growing at a CAGR of 11.5% over the analysis period 2024-2030. IVD Devices, one of the segments analyzed in the report, is expected to record a 14.3% CAGR and reach US$64.1 Billion by the ... Read More
-
Near Infrared Imaging
... at a CAGR of 14.8% over the analysis period 2024-2030. Near Infrared Imaging Devices, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$1.7 Billion by the ... Read More
-
Cell Viability Assays
... at a CAGR of 7.1% over the analysis period 2024-2030. Cell Viability Assay Consumables, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$5.3 Billion by the ... Read More
-
Ceramic Inks
... CAGR of 6.1% over the analysis period 2024-2030. Decorative Inks, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$2.7 Billion by the end of the analysis ... Read More
-
Cereal Bars
... CAGR of 7.7% over the analysis period 2024-2030. Snack Bars, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$20.7 Billion by the end of the analysis ... Read More
-
Cervical Cancer Diagnostic Testing
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Pap Smear Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$5.3 Billion by ... Read More
-
Chiral Chemicals
... CAGR of 6.2% over the analysis period 2024-2030. Traditional Separation Method, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$50.8 Billion by the end of the ... Read More
-
Coconut Milk
... CAGR of 16.1% over the analysis period 2024-2030. Conventional Coconut Milk, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$5.5 Billion by the end of the ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach ... Read More
-
Contract Packaging
... CAGR of 8.7% over the analysis period 2024-2030. Food & Beverage End-Use, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$55.4 Billion by the end of ... Read More
-
Cosmetic Antioxidants
... CAGR of 5.0% over the analysis period 2024-2030. Vitamins, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$54.2 Million by the end of the analysis period. ... Read More
-
Dental Digital X-ray
... at a CAGR of 5.9% over the analysis period 2024-2030. Extraoral X-ray, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Dermal Filler
... CAGR of 8.6% over the analysis period 2024-2030. Botulinum Toxin, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$6.5 Billion by the end of the analysis ... Read More
-
Digital X-ray
... CAGR of 6.3% over the analysis period 2024-2030. Direct Radiography Technology, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$12.3 Billion by the end of the ... Read More
-
Drug Screening
... CAGR of 16.7% over the analysis period 2024-2030. Drug Screening Products, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$16.7 Billion by the end of the ... Read More
-
Duodenoscopes
... 4.3% over the analysis period 2024-2030. Flexible Duodenoscopes, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$175.5 Million by the end of the analysis period. Growth ... Read More
-
Electronic Health Records (EHR)
... 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Acute EHR, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$26.3 Billion by the ... Read More
-
Enterprise Governance, Risk and Compliance (EGRC)
... reach US$194.5 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2024-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach ... Read More
-
Exosomes
... 11.3% over the analysis period 2024-2030. Other Disease Indications, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$377.0 Million by the end of the analysis period. ... Read More
Research Assistance
